The BalancedInvestor Club

TLRY Market Analysis

Overview

Fundamentals

P/E ratio—Forward 1000.00
EPS (TTM)$-14.630.0% YoY
Profit margin-156.7%HEALTHCARE
Market cap$736.8MSmall cap

Wall Street coverage

$10.04median target· current $20.50 (-51.0%)10 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
1000.00
PEG ratio
—
P/B
0.47
P/S (TTM)
0.86
EV/EBITDA
-4.84

Profitability & growth

ROE (TTM)
-63.2%
Operating margin
-52.7%
Revenue growth YoY
-7.8%
Dividend yield
—
Beta
2.11
Last earnings
Apr 1, 2026 · Estimate $0.07 · Reported $0.02
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Tilray Inc

Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.

Classification

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
265 TALBOT STREET WEST, LEAMINGTON, ON
Fiscal year end
May
Latest quarter
Feb 28, 2026
Market cap$736.8M
Shares outstanding$119.6M
52W high$23.20
52W low$3.50

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer